Concepedia
2
Publications
98
Citations
H-Index
2021
Active since
Affiliations
GlaxoSmithKline (United States)(Current)
Katie Thorn is an author at GlaxoSmithKline (United States).
Publications per year
2021–2024
A randomized, placebo-controlled experimental medicine study of RIPK1 inhibitor GSK2982772 in patients with moderate to severe rheumatoid arthritis
Kathleen Weisel, Scott B. Berger, Katie Thorn et al. · Arthritis Research & Therapy · 2021 · 83 citations · Full text
Inhibition of Receptor-Interacting Protein Kinase 1 in Chronic Plaque Psoriasis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
Valerie J. Ludbrook, David C. Budd, Katie Thorn et al. · Dermatology and Therapy · 2024 · 15 citations · Full text
Rows per page
1–2 of 2